Evidence map›Paper›PMID 22382688›Full record

ArticleBritish journal of cancer2012

Predicting the safety and efficacy of buffer therapy to raise tumour pHe: an integrative modelling study.

N K Martin, I F Robey, E A Gaffney, R J Gillies, R A Gatenby, P K Maini

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Acid affairs in anti-tumour immunity.Cancer cell international · 2024
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Targeting tumor-associated acidity in cancer immunotherapy.Cancer immunology, immunotherapy : CII · 2018
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

N K MartinCentre for Mathematical Biology, Mathematical Institute, Oxford University, 24-29 St Giles', Oxford OX1 3LB, UK. Natasha.martin@bristol.ac.uk
I F Robey
E A Gaffney
R J Gillies
R A Gatenby
P K Maini
University of Oxford · GBMoffitt Cancer Center · USUniversity of Arizona · US

Funding

The Physi(ologi)cal Microenvironment and its Role in Tumor Invasion and MetastaseU54CA143970 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI GATENBY, ROBERT A · 2009 to 2014
$9.3M
Causes & Consequences of Acid pH in TumorsR01CA077575 · NCI · UNIVERSITY OF ARIZONA · PI GILLIES, ROBERT J. · 1999 to 2018
$8.5M
Subproject OneU56CA113004 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI DEISBOECK, THOMAS S · 2004 to 2009
$3.4M
Fatty Liver Preventive Effects and High Dose Hepatotoxicity of Tea PolyphenolsR01AT004678 · NCCIH · PENNSYLVANIA STATE UNIVERSITY, THE · PI LAMBERT, JOSHUA D · 2009 to 2013
$1.7M
NCCIH NIH HHS K01AT004678NCCIH NIH HHS R01 AT004678NCI NIH HHS 1U54CA143970-01NCI NIH HHS R01 CA077575NCI NIH HHS U54 CA143970NCI NIH HHS U56 CA113004NCI NIH HHS U56CA113004
6 · The paper itself

Abstract

backgroundClinical positron emission tomography imaging has demonstrated the vast majority of human cancers exhibit significantly increased glucose metabolism when compared with adjacent normal tissue, resulting in an acidic tumour microenvironment. Recent studies demonstrated reducing this acidity through systemic buffers significantly inhibits development and growth of metastases in mouse xenografts.

methodsWe apply and extend a previously developed mathematical model of blood and tumour buffering to examine the impact of oral administration of bicarbonate buffer in mice, and the potential impact in humans. We recapitulate the experimentally observed tumour pHe effect of buffer therapy, testing a model prediction in vivo in mice. We parameterise the model to humans to determine the translational safety and efficacy, and predict patient subgroups who could have enhanced treatment response, and the most promising combination or alternative buffer therapies.

resultsThe model predicts a previously unseen potentially dangerous elevation in blood pHe resulting from bicarbonate therapy in mice, which is confirmed by our in vivo experiments. Simulations predict limited efficacy of bicarbonate, especially in humans with more aggressive cancers. We predict buffer therapy would be most effectual: in elderly patients or individuals with renal impairments; in combination with proton production inhibitors (such as dichloroacetate), renal glomular filtration rate inhibitors (such as non-steroidal anti-inflammatory drugs and angiotensin-converting enzyme inhibitors), or with an alternative buffer reagent possessing an optimal pK of 7.1-7.2.

conclusionOur mathematical model confirms bicarbonate acts as an effective agent to raise tumour pHe, but potentially induces metabolic alkalosis at the high doses necessary for tumour pHe normalisation. We predict use in elderly patients or in combination with proton production inhibitors or buffers with a pK of 7.1-7.2 is most promising.

Indexed as

BuffersAlkalosisAnimalsBicarbonatesHumansHydrogen-Ion ConcentrationMiceModels, BiologicalNeoplasmsBicarbonatesBuffers

Identifiers

PMID22382688
PMCPMC3314784
OpenAlexW2169555555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.